Charles Schwab
ENTL

Charles Schwab’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Charles Schwab’s Portfolio ENTL Stock Details ENTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-45,129
Closed -$1.1M – 3090
2017
Q4 		$1.1M Buy
45,129
+5,416
+14% +$104K ﹤0.01% 2480
2017
Q3 		$734K Buy
39,713
+1,914
+5% +$33.2K ﹤0.01% 2601
2017
Q2 		$626K Buy
37,799
+9,469
+33% +$132K ﹤0.01% 2622
2017
Q1 		$391K Buy
28,330
+9,855
+53% +$158K ﹤0.01% 2731
2016
Q4 		$351K Buy
18,475
+770
+4% +$14.8K ﹤0.01% 2785
2016
Q3 		$393K Buy
17,705
+680
+4% +$12.8K ﹤0.01% 2704
2016
Q2 		$312K Buy
17,025
+210
+1% +$3.62K ﹤0.01% 2771
2016
Q1 		$306K Buy
16,815
+255
+2% +$4.13K ﹤0.01% 2766
2015
Q4 		$280K Buy
16,560
+325
+2% +$5.52K ﹤0.01% 2885
2015
Q3 		$293K Buy
16,235
+945
+6% +$21K ﹤0.01% 2837
2015
Q2 		$396K Buy
+15,290
New +$387K ﹤0.01% 2768

Charles Schwab's ENTL Position: Q1 2018 in Review

Charles Schwab sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 45,129 shares — an estimated $1.1M sold.

Charles Schwab first reported a position in ENTL in Q2 2015 and held it in 11 quarters. The position peaked at $1.1M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

  • Charles Schwab reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Charles Schwab sold 45,129 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $1.1M.
  • Charles Schwab first reported a position in Entellus Medical, Inc. Common Stock in Q2 2015 and held it in 11 quarters.
  • Charles Schwab's Entellus Medical, Inc. Common Stock position peaked at $1.1M in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Charles Schwab's 13F filing for Q1 2018, filed 7 May 2018.